Share this article and save a life!
The ICU just got its first thinking brain drain.
The FDA approved something remarkable yesterday: an AI system that autonomously manages brain pressure in critically ill patients.
BrainSpace’s Intellidrop doesn’t just monitor intracranial pressure. It actively drains cerebrospinal fluid using closed-loop AI, adjusting in real-time to each patient’s personalized pressure goals.
Think about what this means:
Every year, millions of patients with traumatic brain injuries, strokes, or post-surgical complications need precise CSF drainage. One wrong measurement, one delayed adjustment, and you risk permanent brain damage or death.
Until now, this required constant manual monitoring by specialized neuro ICU nurses, already stretched impossibly thin.
📊 The numbers are staggering:
• 1 in 3 people globally will face neurological injury or illness
• ICUs are operating with 20% nursing vacancy rates
• Brain pressure management errors contribute to 30% of neuro ICU complications
But here’s what really excites me:
This isn’t just automation. It’s the birth of Brain Fluid Interface technology, a new category that treats brain fluids as data streams for AI analysis.
The device generates multimodal, contextualized data that trains Physical AI models. We’re literally teaching machines to understand the language of cerebrospinal fluid.
Imagine AI that predicts strokes before symptoms appear. Or systems that detect early Alzheimer’s through CSF patterns. Or personalized brain pressure algorithms that adapt to each patient’s unique neurological fingerprint.
The skeptics will say we’re replacing human judgment with algorithms. But when one neuro ICU nurse manages 4 critical patients simultaneously, isn’t AI augmentation the ethical choice?
This approval signals something bigger: the FDA is ready for autonomous medical AI that makes real-time clinical decisions.
We’re not just monitoring patients anymore. We’re creating intelligent guardians that never sleep, never fatigue, and learn from every patient they treat.
The brain-computer interface revolution isn’t coming through Neuralink.
It’s already here, quietly draining fluid in ICUs across America.
♻️ Repost if AI should guard our most vulnerable organ
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
